Divi’s Laboratories Q1 FY27 PBT tops ₹1,165 crore

Results announced for quarter ended June 30, 2026

Divi’s Laboratories Limited declared its unaudited financial results for the first quarter of FY2026-27, for the period ended June 30, 2026. The company said its Board of Directors approved the results in a meeting held on August 1, 2026. Alongside the financials, the board also cleared certain business items, including senior management changes. The update comes at a time when the stock was trading close to its 52-week high, reflecting heightened attention from investors ahead of the earnings release. The company operates in active pharmaceutical ingredients (APIs), intermediates, and custom synthesis.

Standalone performance: income ₹3,037 crore, PAT ₹891 crore

On a standalone basis, Divi’s Laboratories reported total income of ₹3,037 crore for the quarter. Profit Before Tax (PBT) stood at ₹1,165 crore. Profit After Tax (PAT) for the quarter was ₹891 crore. The company also disclosed that the quarterly financial results include a forex loss of ₹7 crore. These figures form the core of the Q1 FY27 unaudited numbers cleared by the board.

Consolidated performance: income ₹3,144 crore, PAT ₹902 crore

On a consolidated basis, total income for the quarter was ₹3,144 crore. Consolidated PBT was reported at ₹1,180 crore. Consolidated PAT came in at ₹902 crore. The company described the consolidated performance as a significant increase versus the corresponding quarter of the previous financial year, without specifying the exact year-on-year base numbers in the same disclosure.

Key Q1 FY27 numbers at a glance

Stock movement: shares rose near 52-week high on July 31

Divi’s Laboratories shares climbed over 2.8% on July 31, 2026, a day before the Q1 FY27 earnings were scheduled. The move brought the stock close to its 52-week high, according to the update. On the same date, the closing price was reported at ₹8,056.65 on BSE and ₹8,056.00 on NSE. Separately, another market snapshot in the provided data showed the stock at ₹6,806.20 (+0.68%) on BSE at 01:37 PM. The dataset also includes a “current share price” reference around ₹6,807, and a separate CMP figure of ₹7,379.5, indicating multiple point-in-time quotes.

Board meeting, trading window closure, and earnings call

The board meeting to consider and approve the unaudited results for the quarter ended June 30, 2026, was scheduled for August 1, 2026. An earnings conference call was set for 2:00 PM IST on August 1, 2026, to discuss the quarterly performance with analysts and institutional investors. The company said the unaudited financials would be released prior to the call. It also noted that the trading window for insiders was shut from July 1, described as standard practice ahead of results. The disclosure referenced Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

How investors could access the call and follow-up information

Investors were provided the option to join via dial-in or DiamondPass registration. The universal dial-in numbers listed were +91 22 6280 1526 and +91 22 7115 8341. The company also said a transcript of the conference call would be made available on its website, www.divislabs.com, after the call. For additional queries, investor relations contact details were shared, including phone +91 40 66966352 and mobile +91 91542 18881, and email mail@divislabs.com. The registered office address was given as Divi Towers, 1-72/23(P)/DIVIS/303, Cyber Hills, Gachibowli, Hyderabad - 500 032, Telangana, India.

Management changes: retirements and new senior roles

The board approved the appointment of two individuals to Senior Management Personnel roles, effective August 1, 2026. The names and roles of the newly appointed personnel were not specified in the provided extract. Separately, the data includes two senior executives slated to retire effective July 31, 2026: Mr. L. Ramesh Babu (VP – Procurement) and Mr. D. Madhu Babu (VP – Projects). These changes were presented alongside routine corporate actions connected to the results cycle.

Dividend timeline: ₹30 per share, AGM on August 10

Divi’s Laboratories fixed July 24, 2026, as the record date to determine shareholder eligibility for a dividend of ₹30 per equity share for FY2025-26. The board recommended the dividend at its meeting on May 23, 2026, subject to shareholder approval. The dividend was to be placed before shareholders at the 36th AGM scheduled on August 10, 2026. If approved, payment was to commence on or from August 14, 2026, subject to tax deduction at source. The company also noted that ₹30 per share on a face value of ₹2 translates to 1,500%.

Context from prior quarters available in the data

The dataset notes a strong comparison base for Q1 FY26, when Divi’s posted 26.7% profit growth to ₹545 crore on revenue of about ₹2,410 crore, with EBITDA margins above 30%. It also references Q4 FY26 revenue near ₹2,793 crore and profit of about ₹756 crore. A separate quarterly table for earlier periods shows, for Mar 2026, net sales of ₹2,793 crore and PBT of ₹971 crore, and for Jun 2025, net sales of ₹2,357 crore and PBT of ₹747 crore. These historical markers help place Q1 FY27 income of ₹3,037 crore (standalone) and ₹3,144 crore (consolidated) in a recent trend frame.

Market impact and why the update matters

The immediate market focus centered on two tracks: the financial performance and the governance calendar around the announcement. The reported rise of more than 2.8% on July 31, 2026, showed that traders were positioning ahead of the Q1 FY27 numbers and the scheduled earnings call. The explicit disclosure of a ₹7 crore forex loss in the quarter offers a clear line item investors can factor into operating interpretation. The combination of board-approved results, insider trading window closure from July 1, and a fixed call time also provides a structured information flow that typically increases participation from institutional investors.

Conclusion

Divi’s Laboratories reported Q1 FY27 standalone total income of ₹3,037 crore with PBT of ₹1,165 crore, while consolidated total income stood at ₹3,144 crore with PBT of ₹1,180 crore. The board also cleared senior management actions effective around August 1, 2026, and the company held an earnings call at 2:00 PM IST the same day. Separately, shareholders were set to vote on the ₹30 per share dividend at the AGM on August 10, 2026, with payment slated to begin on or from August 14, 2026, if approved.